Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.
about
Thrombin activation and liver inflammation in advanced hepatitis C virus infectionDecreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosisManagement of coagulation abnormalities in liver disease.A conceptual and practical approach to haemostasis in paediatric liver disease.
P2860
Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Decreased tissue factor pathwa ...... but normal TFPI plasma levels.
@en
Decreased tissue factor pathway inhibitor
@nl
type
label
Decreased tissue factor pathwa ...... but normal TFPI plasma levels.
@en
Decreased tissue factor pathway inhibitor
@nl
prefLabel
Decreased tissue factor pathwa ...... but normal TFPI plasma levels.
@en
Decreased tissue factor pathway inhibitor
@nl
P2093
P2860
P356
P1476
Decreased tissue factor pathwa ...... but normal TFPI plasma levels
@en
P2093
Arie P van den Berg
Freeha Arshad
Hans Blokzijl
Jelle Adelmeijer
Robert J Porte
Wilma Potze
P2860
P304
P356
10.1111/BJH.12462
P407
P577
2013-07-11T00:00:00Z